Who Paid My Doc
Duke Kasprisin
Pediatric Hematology-Oncology South Hero, VT Medical Doctor
NPI 1891014262 CMS profile 358650
91 W Shore Rd, South Hero, VT 05486
General payments
$802,189
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Duke Kasprisin of South Hero, VT is reported in the CMS Open Payments database as having received $802,189 across 153 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Pediatric Hematology-Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $89,550 | 12 | |
| 2024 | General | $111,869 | 16 | |
| 2023 | General | $109,335 | 25 | |
| 2022 | General | $89,636 | 24 | |
| 2021 | General | $110,225 | 24 | |
| 2020 | General | $145,350 | 25 | |
| 2019 | General | $146,224 | 27 |
Beside peers
- Duke Kasprisin
- Pediatric Hematology-Oncology median
- Middle half of Pediatric Hematology-Oncology
- National median
In program year 2025, general payments to Duke Kasprisin were reported at $89,550. Among 1,352 Pediatric Hematology-Oncology profiles paid that year, the median was $204 and the middle half received between $80 and $2,819.
Show as a table
| Year | Duke Kasprisin | Pediatric Hematology-Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $146,224 | $184 | $69–$2,094 | $163 |
| 2020 | $145,350 | $220 | $37–$3,941 | $114 |
| 2021 | $110,225 | $366 | $63–$4,909 | $132 |
| 2022 | $89,636 | $181 | $66–$2,775 | $149 |
| 2023 | $109,335 | $175 | $62–$2,600 | $160 |
| 2024 | $111,869 | $227 | $66–$2,992 | $164 |
| 2025 | $89,550 | $204 | $80–$2,819 | $169 |
Breakdown
Records
153 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Pediatric Hematology-Oncology in Vermont
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Hematology-Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Vermont
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.